PZPeng Zhang

Peng Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Peng Zhang has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Angioarchitectural Clues to Durable Endovascular Cure in High-Grade Dural Arteriovenous Fistulas

    by Xin Su, Hongqi Zhang, Peng Zhang, Yongjie Ma

  • Angioarchitectural predictors of failed endovascular treatment in high-grade dural arteriovenous fistulas

    by Xin Su, Zihao Song, Hongqi Zhang, Peng Zhang, Yongjie Ma

    Background: Predictors of endovascular treatment failure in high-grade dural arteriovenous fistulas (DAVFs) with cortical venous drainage (CVD) remain insufficiently characterized. This study aimed to identify angioarchitectural factors associated with failed endovascular treatment in DAVFs with CVD. Methods: Patients with angiographically confirmed DAVFs with CVD who underwent first-line endovascular embolization in the DREAM-INI (Dural Arteriovenous Fistula Research and Management in China) database were retrospectively analyzed. Successful endovascular treatment was defined as durable complete obliteration without the need for additional surgery or radiosurgery. Baseline clinical and angioarchitectural characteristics were compared between successful and unsuccessful treatment groups. Logistic regression was used to identify predictors of treatment success. Results: A total of 415 patients were included. Successful endovascular treatment was achieved in 302 patients (72.8%), whereas 113 patients (27.2%) were classified as having unsuccessful treatment. On multivariable analysis, the presence of a middle meningeal artery feeder was independently associated with successful endovascular treatment. In contrast, pial arterial supply, venous congestion, and multiple fistulas were associated with lower odds of treatment success. Conclusions: In DAVFs with CVD, specific angioarchitectural features are associated with the likelihood of durable cure after endovascular treatment. Middle meningeal artery feeders may facilitate successful embolization, whereas pial arterial supply, venous congestion, and multiple fistulas suggest more complex lesions that may require careful treatment planning and earlier consideration of multimodal strategies.


  • Pretreatment steroids and delayed intervention predict poor long-term outcomes in spinal dural arteriovenous fistulas: a cohort study

    by Chengbin Yang, Yinqing Wang, Huishen Pang, Beichuan Zhao, Tunan Li, Qingyu Jiang, Mingyue Huang, Zihao Song, Lisong Bian, Pengyu Tao, et al.

    Background Spinal dural arteriovenous fistulas (SDAVFs) are frequently misdiagnosed as inflammatory myelitis, resulting in inappropriate steroid therapy that may trigger acute deterioration. However, the long-term prognostic significance of pretreatment steroid exposure is poorly understood. We aimed to analyze long-term outcomes and identify predictors of recovery in the largest SDAVF cohort to date. Methods This retrospective study analyzed 516 patients with confirmed SDAVFs treated between October 2012 and December 2021. All patients were followed for a minimum of 3 years, with a mean follow-up of 79.38 months. The primary outcome was clinical improvement, defined as a ≥1-point decrease on the modified Aminoff–Logue Scale (mALS). Multivariable logistic regression was used to identify independent prognostic factors. Results Clinical improvement on the mALS was observed in 68.7% (355/516) of patients . The multivariable analysis revealed three independent prognostic factors: a longer disease course (OR 0.686; 95% CI 0.534 to 0.882) and pretreatment steroid application (OR 0.559; 95% CI 0.401 to 0.778) were associated with poorer prognosis. Conversely, a more severe pretreatment mALS score paradoxically predicted a higher likelihood of improvement (OR 2.458; 95% CI 1.805 to 3.347). Additionally, sensory deficits proved refractory to treatment in most patients, with only 26.1% experiencing relief. Conclusions The long-term prognosis of treated SDAVFs is multifactorial. A higher mALS score was a strong predictor of greater improvement in patients. This study also highlights that a shorter disease course is strongly predictive of improvement, while pretreatment steroid application is linked to a poorer prognosis. Therefore, prompt and accurate diagnosis and treatment are the prerequisites for improving the prognosis of SDAVFs.

  • Open Access

    Endovascular embolization of tentorial dural arteriovenous fistulas (EMBOTENT): a retrospective multicenter study

    by Dominik F Vollherbst, Nadja Krug, Peng Zhang, Yongjie Ma, Xin Su, Nicola Limbucci, Leonardo Renieri, Pascal J Mosimann, Alexandre Boutet, How-Chung Cheng, et al.

    Background: Tentorial dural arteriovenous fistulas (TDAVFs) are rare but high risk vascular lesions. Although endovascular embolization is often the preferred treatment, large scale data on efficacy and safety are limited. Objective: To investigate the efficacy and safety of endovascular treatment for TDAVFs in a large, retrospective, multicenter cohort, and to analyze lesion characteristics and outcomes according to TDAVF location. Methods: Clinical, radiological, and interventional data from 585 patients treated in 32 international centers in 758 endovascular treatment sessions between 2012 and 2022 were analyzed. Patient demographics, fistula characteristics, endovascular treatment techniques, complications, and outcomes were assessed. Efficacy was measured by occlusion rates, safety by symptomatic complications, and modified Rankin Scale (mRS) scores. Results: In 31.3% of cases TDAVFs initially presented with hemorrhage, including 12.8% in low grade TDAVFs (absence of cortical venous reflux). Transarterial embolization was the primary approach in 84.7% of sessions. Complete occlusion was achieved in 74.2% of cases after the last treatment and 85.7% at the last imaging follow-up (mean 20.9 months). Symptomatic complications occurred in 9.4% of patients, with 2.6% permanent deficits and 1.0% mortality. At the last clinical follow-up (mean 30.6 months), 89.2% of patients had good functional outcome (mRS score 0–2). Location was significantly associated with fistula grade (eg, galenic and tentorial sinus TDAVFs being more often high grade, and torcular TDAVFs being more often low-grade). Conclusions: This large multicenter series demonstrated high occlusion rates, favorable functional outcomes, and acceptable complication rates, supporting endovascular therapy as a treatment of choice for TDAVFs. Considerable hemorrhage rates in low grade TDAVFs support the treatment even in the absence of cortical venous reflux.

  • Intracranial dural arteriovenous fistula following venous sinus stenting: A case series and literature review

    by Xin Su, Yuchen Duan, Zihao Song, Yueqiao Xu, Hongqi Zhang, Peng Zhang, Yongjie Ma

  • Open Access

    Outcomes of Onyx embolisation as primary treatment for intracranial dural arteriovenous fistulas over the past two decades

    by Xin Su, Zihao Song, Yiguang Chen, Hongqi Zhang, Peng Zhang, Yongjie Ma

    Background: Most current studies on Onyx are limited by small sample sizes and often involve its use in combination with other embolic materials, with few investigations specifically evaluating Onyx as a sole embolic agent. Methods: Using the Dural Arteriovenous Fistula Research and Management in China (DREAM-INI) database, we identified patients who underwent primary treatment for dural arteriovenous fistula (DAVF) with Onyx-only embolisation. Data collected included patient demographics, comorbidities, clinical manifestations, DAVF location, arterial supply, Borden and Cognard classifications, endovascular modalities, angiographic results, complications, and both clinical and angiographic follow-up. Multivariate logistic regression analyses were conducted to identify predictors of immediate complete obliteration, complications and poor clinical outcomes. Results: A total of 471 patients with DAVFs underwent primary embolisation using Onyx. The median duration of clinical follow-up was 35.0 months (IQR 10.0–75.3), while the median angiographic follow-up was 24.0 months (IQR 8.0–63.0). Immediate complete obliteration was achieved in 417 patients (88.5%). Procedure-related complications occurred in 31 cases (6.6%). At the final follow-up, 90.6% of patients demonstrated good clinical outcomes. Borden type III DAVFs were positively associated with immediate complete obliteration, whereas the presence of occipital and pial artery feeders was negatively associated. Tentorial location correlated with a higher risk of complications, and age above 65 years emerged as a significant predictor of poor clinical outcome. Conclusions: In this large single-centre study based on the DREAM-INI database, we report satisfactory obliteration rates, a low incidence of complications and favourable outcomes following Onyx-based single-agent primary embolisation for single DAVFs.


  • Low-Grade cavernous sinus dural arteriovenous fistulas derive greater benefit from treatment than Non-Cavernous sinus lesions

    by Xin Su, Ya Gao, Zihao Song, Yiguang Chen, Liyong Sun, Ming Ye, Hongqi Zhang, Peng Zhang, Yongjie Ma

    Background Current evidence suggests that low-grade intracranial dural arteriovenous fistulas (DAVFs) generally follow a benign clinical course. However, due to differences in study populations and institutional expertise, recommendations regarding the treatment of low grade DAVFs remain inconsistent. Some studies advocate for intervention, while others do not. In addition, limited research exists on whether achieving complete obliteration is necessary in the management of low-grade DAVFs. Methods We retrospectively reviewed patients with low-grade DAVFs from the Dural Arteriovenous Fistula Research and Management in China (DREAM-INI) database. Patients with low-grade DAVFs were included and classified into intervention or observation cohorts, as well as into complete or partial occlusion groups, cavernous sinus and non-cavernous sinus groups, among others. Further subgroup analyses and propensity score matching were also performed. The primary comparison focused on their clinical outcomes. Results A total of 327 patients with low-grade DAVFs were identified. The mean age was 52.0 ± 13.2 years, and 55.4% were female. Among the 304 patients (93.0%) who received treatment, 99.3% underwent primarily endovascular embolization. We found no significant differences in clinical outcomes between the treatment and observation cohorts at the last follow-up, even after propensity score matching. However, among patients in the treatment group, complete obliteration and cavernous sinus DAVF were associated with significantly greater symptomatic improvement compared to partial obliteration and non-cavernous sinus DAVF. Progression to high grade DAVF was documented in 0.7% of DAVFs. Conclusions Among treated patients, complete fistula obliteration and cavernous sinus DAVF are associated with better symptomatic improvement compared to partial embolization and non-cavernous sinus DAVF.


  • Clinical outcomes of intracranial dural arteriovenous fistulas with the pseudophlebitic pattern

    by Xin Su, Liyong Sun, Ya Gao, Zihao Song, Yiguang Chen, Hongqi Zhang, Peng Zhang, Yongjie Ma

    Background A pseudophlebitic pattern (PPP) is now widely recognized as an angiographic manifestation of chronic venous congestion in intracranial dural arteriovenous fistulas (DAVFs). Objective To investigate the association between a PPP and chronic venous congestion in patients with intracranial DAVFs. Methods We retrospectively reviewed consecutive patients evaluated over a 21-year period. Angiographic studies were assessed for the presence of PPP, which was defined as serpiginous and tortuous collateral, bridging, and cortical veins with delayed circulation time in the normal brain. Baseline characteristics and follow-up outcomes were compared between patients with DAVF with and without PPP. To reduce selection bias, the two cohorts were matched in a 1:1 ratio using propensity score matching. Results PPP was found in 256 patients (23.3%). In the unmatched cohort, patients with DAVF with PPP showed lower occlusion rates on angiographic follow-up (73.6% vs 92.7%, PConclusions PPP alone is not sufficient as an independent prognostic marker for DAVF. Future studies should aim to develop more comprehensive scoring systems that incorporate detailed angioarchitectural characteristics to enhance prognostic stratification.